Revvity, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7140461093
USD
102.55
-0.71 (-0.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
ResMed, Inc.
STERIS Plc (Ireland)
West Pharmaceutical Services, Inc.
Hologic, Inc.
The Cooper Cos., Inc.
Align Technology, Inc.
Waters Corp.
Zimmer Biomet Holdings, Inc.
Revvity, Inc.
Mettler-Toledo International, Inc.
Baxter International, Inc.
Why is Revvity, Inc. ?
1
Poor Management Efficiency with a low ROCE of 10.24%
  • The company has been able to generate a Return on Capital Employed (avg) of 10.24% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -1.23% and Operating profit at -2.67% over the last 5 years
3
Flat results in Jun 25
  • RAW MATERIAL COST(Y) Grown by 14.62% (YoY)
  • DEBT-EQUITY RATIO (HY) Highest at 31.52 %
4
With ROCE of 4.39%, it has a very expensive valuation with a 1.33 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -10.22%, its profits have risen by 7.8% ; the PEG ratio of the company is 3.1
5
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -10.22% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Revvity, Inc. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Revvity, Inc.
-11.69%
-0.14
38.22%
S&P 500
13.22%
0.64
20.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-1.23%
EBIT Growth (5y)
-2.67%
EBIT to Interest (avg)
10.80
Debt to EBITDA (avg)
2.07
Net Debt to Equity (avg)
0.27
Sales to Capital Employed (avg)
0.25
Tax Ratio
11.35%
Dividend Payout Ratio
11.63%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
10.24%
ROE (avg)
10.51%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
1.42
EV to EBIT
30.33
EV to EBITDA
15.29
EV to Capital Employed
1.33
EV to Sales
4.65
PEG Ratio
3.05
Dividend Yield
0.32%
ROCE (Latest)
4.39%
ROE (Latest)
4.30%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 582.11 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 3.5 times

DEBTORS TURNOVER RATIO(HY)

Highest at 4.45 times

-2What is not working for the Company
RAW MATERIAL COST(Y)

Grown by 14.62% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 31.52 %

Here's what is working for Revvity, Inc.
Operating Cash Flow
Highest at USD 582.11 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Inventory Turnover Ratio
Highest at 3.5 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 4.45 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Revvity, Inc.
Debt-Equity Ratio
Highest at 31.52 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 14.62% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales